These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36746160)

  • 1. Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial.
    Feig DS; Sanchez JJ; Murphy KE; Asztalos E; Zinman B; Simmons D; Haqq AM; Fantus IG; Lipscombe L; Armson A; Barrett J; Donovan L; Karanicolas P; Tobin S; Mangoff K; Klein G; Jiang Y; Tomlinson G; Hamilton J;
    Lancet Diabetes Endocrinol; 2023 Mar; 11(3):191-202. PubMed ID: 36746160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
    Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis.
    Tarry-Adkins JL; Aiken CE; Ozanne SE
    PLoS Med; 2019 Aug; 16(8):e1002848. PubMed ID: 31386659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.
    Dodd JM; Grivell RM; Deussen AR; Hague WM
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010564. PubMed ID: 30039871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.
    Feig DS; Murphy K; Asztalos E; Tomlinson G; Sanchez J; Zinman B; Ohlsson A; Ryan EA; Fantus IG; Armson AB; Lipscombe LL; Barrett JF;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):173. PubMed ID: 27435163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial.
    Chiswick C; Reynolds RM; Denison F; Drake AJ; Forbes S; Newby DE; Walker BR; Quenby S; Wray S; Weeks A; Lashen H; Rodriguez A; Murray G; Whyte S; Norman JE
    Lancet Diabetes Endocrinol; 2015 Oct; 3(10):778-86. PubMed ID: 26165398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes.
    Brown J; Martis R; Hughes B; Rowan J; Crowther CA
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011967. PubMed ID: 28120427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial.
    Dodd JM; Louise J; Deussen AR; Grivell RM; Dekker G; McPhee AJ; Hague W
    Lancet Diabetes Endocrinol; 2019 Jan; 7(1):15-24. PubMed ID: 30528218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5-10 year follow-up of the PregMet randomised controlled trial.
    Hanem LGE; Salvesen Ø; Juliusson PB; Carlsen SM; Nossum MCF; Vaage MØ; Ødegård R; Vanky E
    Lancet Child Adolesc Health; 2019 Mar; 3(3):166-174. PubMed ID: 30704873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin for the treatment of women with gestational diabetes.
    Brown J; Grzeskowiak L; Williamson K; Downie MR; Crowther CA
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012037. PubMed ID: 29103210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of Small for Gestational Age in Women With Type 2 Diabetes in Pregnancy: Who Should Receive Metformin?
    Feig DS; Zinman B; Asztalos E; Donovan LE; Shah PS; Sanchez JJ; Tomlinson G; Murphy KE
    Diabetes Care; 2022 Jul; 45(7):1532-1539. PubMed ID: 35671033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
    Petrie JR; Chaturvedi N; Ford I; Brouwers MCGJ; Greenlaw N; Tillin T; Hramiak I; Hughes AD; Jenkins AJ; Klein BEK; Klein R; Ooi TC; Rossing P; Stehouwer CDA; Sattar N; Colhoun HM;
    Lancet Diabetes Endocrinol; 2017 Aug; 5(8):597-609. PubMed ID: 28615149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months.
    Ijäs H; Vääräsmäki M; Saarela T; Keravuo R; Raudaskoski T
    BJOG; 2015 Jun; 122(7):994-1000. PubMed ID: 25039582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
    Syngelaki A; Nicolaides KH; Balani J; Hyer S; Akolekar R; Kotecha R; Pastides A; Shehata H
    N Engl J Med; 2016 Feb; 374(5):434-43. PubMed ID: 26840133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes.
    Landi SN; Radke S; Engel SM; Boggess K; Stürmer T; Howe AS; Funk MJ
    JAMA Pediatr; 2019 Feb; 173(2):160-168. PubMed ID: 30508164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
    Ahrén B; Masmiquel L; Kumar H; Sargin M; Karsbøl JD; Jacobsen SH; Chow F
    Lancet Diabetes Endocrinol; 2017 May; 5(5):341-354. PubMed ID: 28385659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.
    Russell-Jones D; Vaag A; Schmitz O; Sethi BK; Lalic N; Antic S; Zdravkovic M; Ravn GM; Simó R;
    Diabetologia; 2009 Oct; 52(10):2046-55. PubMed ID: 19688338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.